Skip to main content

Table 1 Treatment Emergent Adverse Events

From: Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study

Adverse event

Group 1

Group 2

Grade 1

Grade 2

Grade 3

Grade 4

Grade 1

Grade 2

Grade 3

Grade 4

Neutropenia

2

1

  

2

 

1

1

Thrombocytopenia

1

  

1

2

 

1

 

Anemia

1

   

1

   

Anorexia

      

1

 

Diarrhea

    

1

   

Increased ALP

    

2

   

Increased ALT

    

1

   

Increased AST

    

1

   

Hypocalcemia

    

1

   

Hypomagnesemia

    

1

   
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us